Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans

Infection and Immunity

Volumn 66, Issue 6, 1998, Pages 2632-2639

  Murphy, Juneann W ^a   Schafer, Fredda ^a   Casadevall, Arturo ^b   Adesina, Adekunle ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CRYPTOCOCCUS NEOFORMANS; DELAYED HYPERSENSITIVITY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

CRYPTOCOCCUS NEOFORMANS;

EID: 0031867452     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.6.2632-2639.1998     Document Type: Article

References (43)

1. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor and gamma Interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725-1731.
2. Aguirre, K. M., P. C. Sayles, G. W. Gibson, and L. L. Johnson. 1996. Resistance to Cryptococcus neoformans is associated with an inflammatory response to Toxoplasma gondii in the central nervous system of mice. Infect. Immun. 64:77-82.
3. Buchanan, K. L., and J. W. Murphy. 1993. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun. 61:2854-2865.
4. Buchanan, K. L., and J. W. Murphy. 1997. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 90:189-197.
5. Buchanan, K. L., and J. W. Murphy. 1994. Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun. 62:2930-2939.
6. Casadevall, A., J. Mukherjee, S. J. N. Devi, R. Schneerson, J. B. Robbins, and M. D. Scharff. 1992. Antibodies elicited by a Cryptococcus neoformans glucuronoxylomannan-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. 65:1086-1093.
7. Casadevall, A., J. Mukherjee, and M. D. Scharff. 1992. Monoclonal antibody ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154:27-35.
8. L usage in polysaccharide binding antibodies. J. Exp. Med. 174:151-160.
9. Diamond, R. D., and J. E. Bennett. 1974. Prognostic factors in cryptococeal meningitis. A study in 111 cases. Ann. Intern. Med. 80:176-181.
10. Doyle, H. A., and J. W. Murphy. 1997. MIP-1α contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J. Leukocyte Biol. 61:147-155.
11. Dromer, F., J. Charreire, A. Contrepois, C. Carbon, and P. Yeni. 1987. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55:749-752.
12. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for the determination of sugars and related substances. Anal. Chem. 28:350-356.
13. Fidel, P. L., Jr., and J. W. Murphy. 1990. Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response. Infect. Immun. 58:393-398.
14. Fidel, P. L., Jr., and J. W. Murphy. 1989. Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation. Infect. Immun. 57:1158-1164.
15. Flesch, I. E., G. Schwamberger, and S. H. Kaufmann. 1989. Fungicidal activity of IFN-γ-activated macrophages. Extracellular killing of Cryptococcus neoformans. J. Immunol. 142:3219-3224.
16. Gadebusch, H. H. 1958. Active immunization against Cryptococcus neoformans. J. Infect. Dis. 102:219-226.
17. Gentry, L. O., and J. S. Remington. 1971. Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J. Infect. Dis. 123:22-31.
18. Graybill, J. R., and R. L. Taylor. 1978. Host defense in cryptococcosis. I. An in vivo model for evaluating immune responses. Int. Arch. Allergy Appl. Immunol. 57:101-108.
19. Hidore, M. R., N. Nabavi, F. Sonleitner, and J. W. Murphy. 1991. Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect. Immun. 59:1747-1754.
20. Hoff, C. L. 1942. Immunity studies of Cryptococcus hominis (Torula histolytica) in mice. J. Lab. Clin. Med. 27:751-754.
21. Kawakami, K., S. Kohno, J. I. Kadota, M. Tohyama, K. Teruya, N. Kudeken, A. Saito, and K. Hara. 1945. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-γ and its protective effect against cryptococcal infection. Microbiol. Immunol. 39:135-143.
22. Khakpour, F. R., and J. W. Murphy. 1987. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Infect. Immun. 55:1657-1662.
23. Kligman, A. M. 1947. Studies of the capsular substance of Torula histolytica and the immunologic properties of torula cells. J. Immunol. 57:395-401.
24. Levitz, S. M., and D. J. DiBenedetto. 1988. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect. Immun. 56:2544-2551.
25. Levitz, S. M., and M. P. Dupont. 1993. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. J. Clin. Invest. 91:1490-1498.
26. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
27. Mody, C. H., R. Paine III, C. Jackson, G. H. Chen, and G. B. Toews. 1994. CDS cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans. J. Immunol. 152:3970-3979.
28. Mody, C. H., C. L. Tyler, R. G. Sitrin, C. Jackson, and G. B. Toews. 1991. Interferon-γ activates rat alveolar macrophages for anticryptococcal activity. Am. J. Respir. Cell Mol. Biol. 5:19-26.
29. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
30. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1995. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect. Immun. 63:3353-3359.
31. Mukherjee, J., L. Zuckier, M. D. Scharff, and A. Casadevall. 1994. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob. Agents Chemother. 38:580-587.
32. Murphy, J. W. 1989. Clearance of Cryptococcus neoformans from immunologically suppressed mice. Infect. Immun. 57:1946-1952.
33. Murphy, J. W. 1993. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect. Immun. 61:4750-4759.
34. Murphy, J. W., J. A. Gregory, and H. W. Larsh. 1974. Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect. Immun. 9:404-409.
35. Murphy, J. W., M. R. Hidore, and S. C. Wong. 1993. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J. Clin. invest. 91:1553-1566.
36. Murphy, J. W., and J. W. Moorhead. 1982. Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J. Immunol. 128:276-283.
37. Murphy, J. W., and R. L. Mosley. 1985. Regulation of cell-mediated immunity in Cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2). J. Immunol. 134:577-584.
38. Murphy, J. W., and N. Pahlavan. 1979. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in Cryptococcosis. Infect. Immun. 25:284-292.
39. Muth, S. M., and J. W. Murphy. 1995. Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect. Immun. 63:1637-1644.
40. Muth, S. M., and J. W. Murphy. 1995. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on the direct anticryptococcal activities of murine T lymphocytes. Infect. Immun. 63:1645-1651.
41. Powderly, W. G. 1992. Therapy for cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 14:S54-S59.
42. Salkowski, C., and E. Balish. 1991. A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic Cryptococcosis. Infect. Immun. 59:486-193.
43. Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of the initial infection in recurrent cryptococcal meningitis. Lancet 341:505-596.